Article
Risk of second primary malignancy after radioiodine for thyroid carcinoma: a SEER-based study
2022-07-06
Abstract excerpt
<title>Abstract</title> <p>Purpose The objective of this study is to evaluate the benefits of radioactive iodine (RAI) treatment and the risk of second primary malignant (SPM) in RAI treated patients. Methods The cohort for this analysis consisted of individuals diagnosed with a first primary differentiated thyroid carcinoma (DTC), reported by SEER database in 1988–2016. Overall survival (OS) difference was est...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 56a062ff-a247-52ad-9568-a8ef91061a77
- DOI
- 10.21203/rs.3.rs-1808496/v1
